Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence and satisfaction study of Loceryl versus Ciclopoli in toenail onychomycosis
2015-001237-24Phase 4Completed
- Sponsor
- Galderma
- Start
- Jun 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of amorolfine, Ciclopoli in onychomycosis, Distal Lateral Subungual Onychomycosis (DLSO), sponsored by Galderma. Started Jun 2015; status: completed.
02
Drugs
amorolfineCiclopoli
03
Conditions
onychomycosisDistal Lateral Subungual Onychomycosis (DLSO)
Beyond the preview
Go deeper on 2015-001237-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001237-24.